News

03Feb

Invivoscribe’s EHA Symposiums Now Available on Demand

Products are for professional/laboratory use only.

The Invivoscribe symposiums presented during the 25^th European Hematology Association Virtual Congress are now available to watch on demand.

eha symposium, invivoscribe, MRD, MRD monitoring, next generation analysis, next generation sequencing, NGS

02Feb

Molecular

Utility of NGS Assays for the Evaluation of Lymphoid Malignancies – Webinar

Products are for professional/laboratory use only.

This webinar will explore how insights gained through NGS translate to the development of improved treatment of lymphoid malignancies.

invivoscribe, lymphoid malignancies, NGS, webinar

03Feb

Molecular

Study Reviewing 2,500 Performed Idylla Tests Shows Generation of Valid Results in 98.1% of Cases and Outperformance over Reference Methods

Products are for professional/laboratory use only.

Press Release: Mechelen, Belgium, 27 June 2018

biocartis, braf, cancer, EGFR, idylla, KRAS, next generation sequencing, NGS, nras, tumour

03Feb

Molecular

Study Demonstrates Ability of Idylla EGFR Mutation Test to Produce a Result in 80% of Failed Next Generation Sequencing Lung Cancer Tests

Products are for professional/laboratory use only.

A new publication in the Journal of Clinical Pathology demonstrated that the Idylla EGFR Mutation Test (CE-IVD) was able to rescue 80% of the EGFR samples whose assessment was unsuccessful with Next Generation Sequencing (NGS).

biocartis, EGFR, idylla, lung cancer, next generation sequencing, NGS